Pharmaceutical Industry Information Portal

HomeNews

News

Veru shares up 38.5% YTD, but Q2 loss missed earnings expectations

Veru Inc. came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares...

Sun Pharma shares up 4% after FDA approves mesalamine capsules

Sun Pharmaceutical Industries Limited, announced that it has received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for generic Mesalamine...

SK Biopharmaceuticals revenues fell 70% in the first quarter

SK Biopharmaceuticals’ sales plummeted in the first quarter, compared to a year earlier, due to the base effect of a one-off income from a...

Merck KGaA expects adjusted profit to rise to 9% due to demand for laboratory products

Germany's Merck KGaA said it expects earnings growth of up to 9% this year, mainly driven by drugmakers' demand for its laboratory gear business,...

Yale, JDRF and NexImmune, $600,000 grant for diabetes research

NexImmune, Inc., Yale and JDRF have begun a two-year project to explore the use of NexImmune’s AIM nanoparticles in combination with an anti-CD3 mAb...

Roche’s 2nd cancer immunotherapy trial fails, shares down the most in a year

Development of a new cancer treatment pioneered by Roche was thrown into doubt on Wednesday when the immunotherapy drug failed to slow progression of...
spot_img

Expert Articles

spot_img